Drug Pricing Update: PMPRB launches consultation on Draft Guidelines for price review
Federal Court declares patent ineligible for listing during PM(NOC) infringement action
Federal Court of Appeal confirms that the PMPRB has no jurisdiction over unpatented medicines
Supreme Court of Canada grants leave to appeal methods of medical treatment patentability decision
Federal Court addresses treatment and formulation patent claims in PMNOC case
British Columbia signs first funding agreement under the national rare disease strategy
Drug pricing: PMPRB launches next phase of the Guidelines consultation
CADTH to Transform into Canada’s Drug Agency
Drug pricing: PMPRB announces next steps in Guidelines consultation
Subscribe: Subscribe via RSS
Firm/Org